CN102127562B - 一种种子特异型表达载体及其构建方法与应用 - Google Patents
一种种子特异型表达载体及其构建方法与应用 Download PDFInfo
- Publication number
- CN102127562B CN102127562B CN2010105800170A CN201010580017A CN102127562B CN 102127562 B CN102127562 B CN 102127562B CN 2010105800170 A CN2010105800170 A CN 2010105800170A CN 201010580017 A CN201010580017 A CN 201010580017A CN 102127562 B CN102127562 B CN 102127562B
- Authority
- CN
- China
- Prior art keywords
- apolipoproteins
- gene
- oil body
- milano variant
- expression vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000013604 expression vector Substances 0.000 title claims abstract description 41
- 238000010276 construction Methods 0.000 title abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 181
- 241000196324 Embryophyta Species 0.000 claims abstract description 128
- 238000000034 method Methods 0.000 claims abstract description 59
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 15
- 108010071619 Apolipoproteins Proteins 0.000 claims description 160
- 102000007592 Apolipoproteins Human genes 0.000 claims description 160
- 239000003921 oil Substances 0.000 claims description 62
- 235000019198 oils Nutrition 0.000 claims description 62
- 102000004169 proteins and genes Human genes 0.000 claims description 55
- 235000019483 Peanut oil Nutrition 0.000 claims description 36
- 239000000312 peanut oil Substances 0.000 claims description 36
- 230000004927 fusion Effects 0.000 claims description 32
- 239000013612 plasmid Substances 0.000 claims description 30
- 239000000828 canola oil Substances 0.000 claims description 28
- 235000019519 canola oil Nutrition 0.000 claims description 28
- 230000029087 digestion Effects 0.000 claims description 24
- 239000012634 fragment Substances 0.000 claims description 23
- 108020004705 Codon Proteins 0.000 claims description 15
- 241000589158 Agrobacterium Species 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 108010042407 Endonucleases Proteins 0.000 claims description 7
- 102000004533 Endonucleases Human genes 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- 230000009466 transformation Effects 0.000 claims description 7
- 238000013016 damping Methods 0.000 claims description 6
- 238000013461 design Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 230000001404 mediated effect Effects 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 108700010070 Codon Usage Proteins 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 230000008676 import Effects 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 3
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 claims 1
- 230000014509 gene expression Effects 0.000 abstract description 24
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 235000017060 Arachis glabrata Nutrition 0.000 abstract description 7
- 244000105624 Arachis hypogaea Species 0.000 abstract description 7
- 235000010777 Arachis hypogaea Nutrition 0.000 abstract description 7
- 235000018262 Arachis monticola Nutrition 0.000 abstract description 7
- 235000020232 peanut Nutrition 0.000 abstract description 7
- 108010059886 Apolipoprotein A-I Proteins 0.000 abstract description 6
- 102000005666 Apolipoprotein A-I Human genes 0.000 abstract description 6
- 101710089395 Oleosin Proteins 0.000 abstract description 4
- 238000005520 cutting process Methods 0.000 abstract description 2
- 241000208818 Helianthus Species 0.000 abstract 1
- 235000003222 Helianthus annuus Nutrition 0.000 abstract 1
- 235000019484 Rapeseed oil Nutrition 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 46
- 108020004414 DNA Proteins 0.000 description 28
- 239000000047 product Substances 0.000 description 24
- 230000009261 transgenic effect Effects 0.000 description 22
- 239000007788 liquid Substances 0.000 description 21
- 108010010234 HDL Lipoproteins Proteins 0.000 description 18
- 102000015779 HDL Lipoproteins Human genes 0.000 description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 11
- 230000004087 circulation Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 9
- 244000020518 Carthamus tinctorius Species 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 108010007622 LDL Lipoproteins Proteins 0.000 description 9
- 102000007330 LDL Lipoproteins Human genes 0.000 description 9
- 238000000246 agarose gel electrophoresis Methods 0.000 description 9
- 230000003321 amplification Effects 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000009089 cytolysis Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000628997 Flos Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 108020005038 Terminator Codon Proteins 0.000 description 3
- 230000003143 atherosclerotic effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000009514 concussion Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000012743 protein tagging Effects 0.000 description 3
- 238000012797 qualification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 244000060924 Brassica campestris Species 0.000 description 2
- 235000005637 Brassica campestris Nutrition 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 108010016634 Seed Storage Proteins Proteins 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 238000005267 amalgamation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 101150010487 are gene Proteins 0.000 description 2
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 101710135378 pH 6 antigen Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229910052902 vermiculite Inorganic materials 0.000 description 2
- 235000019354 vermiculite Nutrition 0.000 description 2
- 239000010455 vermiculite Substances 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010088350 Lactate Dehydrogenase 5 Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QWXOJIDBSHLIFI-UHFFFAOYSA-N [3-(1-chloro-3'-methoxyspiro[adamantane-4,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC2CC(Cl)(C4)C3)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 QWXOJIDBSHLIFI-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 244000037640 animal pathogen Species 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002337 anti-port Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 108010040033 apolipoprotein A-I Milano Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 108010087967 type I signal peptidase Proteins 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105800170A CN102127562B (zh) | 2009-12-09 | 2010-12-09 | 一种种子特异型表达载体及其构建方法与应用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910250703 | 2009-12-09 | ||
CN200910250703.9 | 2009-12-09 | ||
CN2010105800170A CN102127562B (zh) | 2009-12-09 | 2010-12-09 | 一种种子特异型表达载体及其构建方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102127562A CN102127562A (zh) | 2011-07-20 |
CN102127562B true CN102127562B (zh) | 2013-01-30 |
Family
ID=44145108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105800170A Expired - Fee Related CN102127562B (zh) | 2009-12-09 | 2010-12-09 | 一种种子特异型表达载体及其构建方法与应用 |
Country Status (3)
Country | Link |
---|---|
US (1) | US9745362B2 (zh) |
CN (1) | CN102127562B (zh) |
WO (1) | WO2011069459A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102925480B (zh) * | 2012-11-02 | 2014-05-07 | 浙江大学 | 一种抑制水稻2-pgk基因表达的植物表达载体及培育低植酸水稻的方法 |
CN104232654A (zh) * | 2013-06-07 | 2014-12-24 | 中国科学院植物研究所 | 一种表达盒及其在培育种子油脂含量增高的转基因植物中的应用 |
CN109706150B (zh) * | 2019-01-24 | 2020-07-28 | 山东省花生研究所(山东省农业科学院花生工程技术研究中心) | 一种花生种子特异表达启动子ahssp29及其应用 |
CN114959919A (zh) * | 2021-02-23 | 2022-08-30 | 中国科学院天津工业生物技术研究所 | 一种构建酿酒酵母人工小启动子文库的方法及应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101586117A (zh) * | 2009-03-20 | 2009-11-25 | 中山大学 | 花生油体蛋白基因启动子在驱动外源基因在转基因植物种子中特异表达上的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6288304B1 (en) * | 1991-02-22 | 2001-09-11 | Sembiosys Genetics Inc. | Expression of somatotropin in plant seeds |
WO1993010241A1 (en) * | 1991-11-20 | 1993-05-27 | Calgene, Inc. | FATTY ACYL-CoA: FATTY ALCOHOL O-ACYLTRANSFERASES |
US5643757A (en) * | 1994-03-21 | 1997-07-01 | American Cyanamid Company | High yield production of human apolipoprotein A1 in E. coli. |
WO1998018948A1 (en) | 1996-10-31 | 1998-05-07 | National Research Council Of Canada | Flax promoters for manipulating gene expression |
WO2001016340A1 (en) | 1999-08-27 | 2001-03-08 | Sembiosys Genetics Inc. | Flax seed specific promoters |
TWI317736B (en) * | 2000-12-19 | 2009-12-01 | Sembiosys Genetics Inc | Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications |
US20060179514A1 (en) * | 2001-07-05 | 2006-08-10 | Sembiosys Genetics, Inc. | Methods for the production of multimeric protein complexes, and related compositions |
TW200526778A (en) * | 2003-11-14 | 2005-08-16 | Sembiosys Genetics Inc | Methods for the production of apolipoproteins in transgenic plants |
JP2009538622A (ja) * | 2006-05-30 | 2009-11-12 | ダウ グローバル テクノロジーズ インコーポレイティド | コドン最適化法 |
WO2008017906A1 (en) * | 2006-08-10 | 2008-02-14 | Plantechno S.R.L. | In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
CN101037692A (zh) | 2006-12-28 | 2007-09-19 | 吉林农业大学 | 利用植物油体表达人胰岛素的方法 |
-
2010
- 2010-12-09 CN CN2010105800170A patent/CN102127562B/zh not_active Expired - Fee Related
- 2010-12-09 US US13/515,209 patent/US9745362B2/en active Active
- 2010-12-09 WO PCT/CN2010/079620 patent/WO2011069459A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101586117A (zh) * | 2009-03-20 | 2009-11-25 | 中山大学 | 花生油体蛋白基因启动子在驱动外源基因在转基因植物种子中特异表达上的应用 |
Non-Patent Citations (2)
Title |
---|
李小东.花生种子特异表达载体构建与农杆菌介导基因转化技术体系的优化.《山东农业大学博士论文》.2009,全文. * |
赵传志.以油体作为生物反应器的研究进展.《生物技术通报》.2008,(第2 期),p73-76,79. * |
Also Published As
Publication number | Publication date |
---|---|
CN102127562A (zh) | 2011-07-20 |
US9745362B2 (en) | 2017-08-29 |
WO2011069459A1 (zh) | 2011-06-16 |
US20120288893A1 (en) | 2012-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2006454C (en) | Potatoe tuber specific transcriptional regulation | |
US5436394A (en) | Plasmid for the preparation of transgenic plants with a change in habit and yield | |
CN101815784A (zh) | 植物系统中外来核酸和多肽的产生 | |
JP2002501755A (ja) | 植物及び植物の部分からポリペプチドを回収するための方法 | |
CN102127562B (zh) | 一种种子特异型表达载体及其构建方法与应用 | |
CN109111514A (zh) | 兼抗纹枯病和根腐病的转基因小麦的培育方法及其相关生物材料 | |
CN104946656A (zh) | 一种人源碱性成纤维细胞生长因子、烟草叶绿体表达载体及生产方法 | |
CN102757487A (zh) | 植物矮化相关蛋白GA2ox及其编码基因和应用 | |
CN108070578A (zh) | 一种与植物耐逆性相关蛋白GmHAD1及其编码基因与应用 | |
CN107815452A (zh) | 一种植物叶片特异性表达的启动子及其应用 | |
CN109266647B (zh) | 水稻二化螟为害诱导型启动子及其应用 | |
CN106496313A (zh) | 抗病相关蛋白IbSWEET10及其编码基因与应用 | |
US5177011A (en) | Plant elongation factor promoters, coding sequences and uses | |
CN114703199B (zh) | 一种植物抗旱性相关的基因TaCML46及应用 | |
CN110184279A (zh) | 甜菊中一个新的促进分枝发育基因SrDREB2A及其表达载体和应用 | |
CN102268451B (zh) | 一种含有人胰岛素基因的表达载体及其构建方法与应用 | |
EP0429538B1 (en) | Plant elongation factor, promoters, coding sequences and uses | |
WO1998000436A1 (en) | Plant plastid division genes | |
CN107641155A (zh) | 一种在植物中表达重组人血清白蛋白的方法 | |
CN103261419A (zh) | 一种调控植物花粉育性的构建体及其使用方法 | |
CN106520721A (zh) | 一种高抗草甘膦epsp合酶及其编码基因的应用 | |
KR102046117B1 (ko) | 식물의 캘러스를 이용한 재조합 인간 인슐린 유사 성장인자-i 단백질의 생산방법 | |
CN102321665B (zh) | 一种在花生种子中表达人humanin蛋白的方法 | |
CN115927394B (zh) | 玉米VPS23类似基因ZmVPS23L及其应用 | |
KR20050027838A (ko) | 식물체에서 발현된 재조합 인간 성장호르몬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170112 Address after: 050035 Hebei province high tech Zone, Yangtze River Road, No., run the headquarters of the international building, room 2, No. 501, room 319 Patentee after: Hebei new Xinuo Biological Medicine Technology Co Ltd Address before: 050026 Hebei Province, Shijiazhuang city Yuhua District Road No. 88 Fangxing Patentee before: An Shengjun Patentee before: Chai Xiqing Patentee before: Wang Kunsheng |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210106 Address after: 050026 No.88, Fangxing Road, Yuhua District, Shijiazhuang City, Hebei Province Patentee after: HEBEI CHEMICAL & PHARMACEUTICAL College Address before: 050035 Room 501, International Building 2, Runjiang headquarters, 319 Changjiang Avenue, high tech Zone, Shijiazhuang City, Hebei Province Patentee before: Hebei new Xinuo Biological Medicine Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130130 Termination date: 20201209 |